We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Cars.com
CARS
$662M
| $4.07M | 0.2% |
206,400
+36,400
| +21% | +$778K |
|
|
AMRN
152
CALL
Amarin Corp
AMRN
$299M
| $4.02M | 0.2% |
10,375
-8,250
| -44% | -$3.02M |
|
153
PUT
Teladoc Health
TDOC
$1.22B
| $3.98M | 0.2% |
+60,000
| New | +$3.5M |
|
|
SRDX
154
DELISTED
Surmodics
SRDX
| $3.85M | 0.19% |
+89,088
| New | +$3.76M |
|
|
PTLA
155
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.8M | 0.19% |
+140,000
| New | +$4.39M |
|
|
156
PUT
Bristol-Myers Squibb
BMY
$133B
| $3.79M | 0.19% |
83,500
-415,000
| -83% | -$19.3M |
|
157
PUT
Bausch Health
BHC
$2.58B
| $3.78M | 0.19% |
+150,000
| New | +$3.56M |
|
|
GBT
158
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.73M | 0.19% |
71,000
+50,504
| +246% | +$2.9M |
|
159
CALL
Upland Software
UPLD
$12.8M
| $3.73M | 0.19% |
+8,190
| New | +$3.75M |
|
|
MDCO
160
DELISTED
Medicines Co
MDCO
| $3.68M | 0.19% |
101,000
-24,560
| -20% | -$802K |
|
161
CALL
RH
RH
$3.13B
| $3.64M | 0.18% |
31,500
| – | – |
|
162
PUT
Ashland
ASH
$3.33B
| $3.6M | 0.18% |
+45,000
| New | +$3.48M |
|
163
Sony
SONY
$137B
| $3.58M | 0.18% |
+341,500
| New | +$3.35M |
|
164
PUT
Carvana
CVNA
$68.6B
| $3.52M | 0.18% |
+281,500
| New | +$3.62M |
|
165
CALL
Live Nation Entertainment
LYV
$40.6B
| $3.52M | 0.18% |
+53,200
| New | +$3.42M |
|
166
CALL
NovoCure
NVCR
$1.73B
| $3.48M | 0.18% |
+55,000
| New | +$2.79M |
|
|
RST
167
CALL
DELISTED
ROSETTA STONE INC
RST
| $3.47M | 0.17% |
151,800
+1,800
| +1% | +$43.3K |
|
168
CALL
Pampa Energía
PAM
$4.75B
| $3.47M | 0.17% |
+100,000
| New | +$2.61M |
|
169
CALL
Rogers Corp
ROG
$2.21B
| $3.45M | 0.17% |
+20,000
| New | +$3.26M |
|
170
PUT
Acadia Pharmaceuticals
ACAD
$4.43B
| $3.42M | 0.17% |
127,900
+92,900
| +265% | +$2.37M |
|
171
CALL
Enphase Energy
ENPH
$4.96B
| $3.33M | 0.17% |
+182,900
| New | +$2.52M |
|
172
CALL
Champion Homes
SKY
$4.37B
| $3.29M | 0.17% |
+120,000
| New | +$2.73M |
|
|
BPMC
173
PUT
DELISTED
Blueprint Medicines
BPMC
| $3.26M | 0.16% |
+34,600
| New | +$2.86M |
|
174
PUT
Tractor Supply
TSCO
$16.1B
| $3.26M | 0.16% |
+150,000
| New | +$3.1M |
|
175
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $3.25M | 0.16% |
38,000
+24,500
| +181% | +$2.1M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.